Skip to main content
Contact Us
Subscribe
E-Edition
96°
Site search
Search
Menu
Open user controls
Log In Using Your Account
Log In
Don't have an account?
Sign Up Today
My Account
Dashboard
Profile
Saved items
Logout
Home
About Us
Contact Us
Advertise
Terms and Conditions
Privacy Policy
Home Delivery
Subscription Services
Place an Ad
Promote Your Event
Local Weather
News
Sports
Obits
Multimedia
Photo Galleries
Videos
e-Edition
Classifieds
Real Estate
Property For Rent
Cars & Vehicles
Jobs
Items For Sale
Pets
Auctions, Estate & Garage Sales
Services
Community
Personals
Place An Ad
Subscribe
Best of 2024
Archives
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Latest News about Eli Lilly And Co
Recent news which mentions Eli Lilly And Co
< Previous
1
2
3
4
5
6
7
8
9
...
11
12
Next >
Healthy Returns: Diabetes drug Ozempic may lower dementia risk, nicotine use
Today 10:52 EDT
Tags
UnitedHealth Group Inc
Pfizer Inc
Biotech and Pharmaceuticals
From
CNBC.com News
Healthy Returns: Drugmakers are racing to develop more convenient weight loss pills
July 11, 2024
Tags
Biotech and Pharmaceuticals
Healthy Returns
Health care industry
From
CNBC.com News
Pfizer moves forward with once-daily version of weight loss pill after setbacks
July 11, 2024
Tags
Health care industry
Business
Companies
From
CNBC.com News
Jim Cramer on Hims & Hers Health stock: 'I bet the business stays strong'
July 10, 2024
Tags
Stock markets
Mad Money
Investing
From
CNBC.com News
Jim Cramer reviews 8 companies that could top $1 trillion in market cap
July 10, 2024
Tags
Investment strategy
Business
Microsoft Corp
From
CNBC.com News
FTC to sue drug middlemen over prices of medications including insulin
July 10, 2024
Tags
Politics
Health & Science
Pharmaceuticals
From
CNBC.com News
Companies besides tech can reach megacap status, Jim Cramer says
July 08, 2024
Tags
Investing
Alphabet Inc
Eli Lilly and Co
From
CNBC.com News
This ETF is trying to satisfy appetites for weight loss stocks
July 06, 2024
Tags
Eli Lilly and Co
Investing
Novo Nordisk A/S
From
CNBC.com News
Healthy Returns: Brain implant company Paradromics launches patient registry ahead of human trial
July 03, 2024
Tags
Health care industry
Technology
Healthy Returns
From
CNBC.com News
CNBC Daily Open: Tesla soars, S&P closes above 5,500
July 03, 2024
Tags
NVIDIA Corp
Oil and Gas
Inflation
From
CNBC.com News
CNBC Daily Open: Tesla soars, S&P closes above 5,500
July 02, 2024
Tags
Asia Markets
Market Outlook
Pharmaceuticals
From
CNBC.com News
FDA approves Eli Lilly Alzheimer’s drug, expanding treatment options in the U.S.
July 02, 2024
Tags
Health & Science
Pharmaceuticals
US: News
From
CNBC.com News
Watch now: ETF Edge on reshoring trends, weight loss drugs and more
July 01, 2024
Tags
Investing
US: News
Eli Lilly and Co
From
CNBC.com News
Healthy Returns: Eli Lilly, other drugmakers show off encouraging weight loss drug data
June 26, 2024
Tags
Gilead Sciences Inc
Health & Science
Viking Therapeutics Inc
From
CNBC.com News
Jim Cramer's top picks for pet-centric stocks
June 25, 2024
Tags
Business
Investment Strategy
Investment strategy
From
CNBC.com News
Novo Nordisk's Wegovy weight loss drug approved in China
June 25, 2024
Tags
Pharmaceuticals
US Top News and Analysis
China Economy
From
CNBC.com News
Novo Nordisk to build $4.1 billion North Carolina facility to boost output of Wegovy, Ozempic
June 24, 2024
Tags
Eli Lilly and Co
US: News
Business News
From
CNBC.com News
Eli Lilly expects FDA decision on weight loss drug Zepbound for sleep apnea as early as end of the year
June 21, 2024
Tags
Biotechnology
Biotech and Pharmaceuticals
Science
From
CNBC.com News
Weight loss drug contender Zealand Pharma jumps 23% on trial results
June 21, 2024
Tags
Novo Nordisk A/S
Eli Lilly and Co
Breaking News: Markets
From
CNBC.com News
Healthy Returns: More U.S. employers are now covering GLP-1s for weight loss
June 18, 2024
Tags
Healthy Returns
Health care industry
Health & Science
From
CNBC.com News
How Eli Lilly is managing soaring demand for GLP-1s, according to outgoing CFO Anat Ashkenazi
June 17, 2024
Tags
Business News
Biotechnology
Biotech and Pharmaceuticals
From
CNBC.com News
Jim Cramer says Eli Lilly isn't a 'one trick pony' after FDA advisers endorse its Alzheimer's drug
June 11, 2024
Tags
Investment strategy
Investment Strategy
Business
From
CNBC.com News
FDA advisors recommend Eli Lilly's Alzheimer's drug donanemab, paving way for approval
June 10, 2024
Tags
Science
Business News
Eli Lilly and Co
From
CNBC.com News
Jim Cramer's week ahead: Fed meeting and CPI report
June 07, 2024
Tickers
RH
Tags
U/S/ Markets
Broadcom Inc
Eli Lilly and Co
From
CNBC.com News
Healthy Returns: Drugmakers release promising cancer drug data – and AstraZeneca wins big
June 07, 2024
Tags
Biotech and Pharmaceuticals
Pfizer Inc
Merck & Co Inc
From
CNBC.com News
Alphabet's new CFO was in the middle of the GLP-1 boom. Now she's onto generative AI
June 06, 2024
Tags
Pharmaceuticals
Internet
Technology
From
CNBC.com News
Alphabet taps Eli Lilly's Anat Ashkenazi as new CFO
June 05, 2024
Tags
Technology
Eli Lilly and Co
Alphabet Inc
From
CNBC.com News
Why half of all workers may struggle to get weight-loss drug health insurance coverage
May 30, 2024
Tags
Weight management
Health & Science
Health insurance
From
CNBC.com News
Telehealth company Ro launches GLP-1 supply tracker to help patients navigate shortages
May 29, 2024
Tags
Biotechnology
Biotech and Pharmaceuticals
Business News
From
CNBC.com News
This new weight loss drug ETF bets big on two of the industry's leading players
May 27, 2024
Tags
Novo Nordisk A/S
U/S/ Markets
Eli Lilly and Co
From
CNBC.com News
< Previous
1
2
3
4
5
6
7
8
9
...
11
12
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.